Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
33 pending office actions • 28 art units • 32 examiners • 0 of 33 (0%) have an AI response strategy ready • 27 patents granted in the last 365 days
University of Kentucky Research Foundation has 33 pending office actions in Biotechnology & Pharmaceuticals. The matters span 32 distinct examiners and 27 distinct art units, creating broad distribution across both personnel and technical examination groups.
TATGE, LEXUS MARC is the busiest examiner, with 2 pending actions. The small difference between the action and examiner totals shows limited examiner concentration, while the art-unit spread indicates substantial technical diversity.
A centralized portfolio process can identify recurring biotechnology issues, but prosecution should remain tailored to the relevant art unit and examiner. Counsel should prioritize consistent disclosure and claim terminology, supported by matter-specific prior-art analysis and response calendars.
Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 5 (15%) |
| §103 only | 8 (24%) |
| §102 only | 2 (6%) |
| §112 only | 1 (3%) |
| Double-patenting + other | 3 (9%) |
| Multi-statute (no §101) | 14 (42%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TATGE, LEXUS MARC | 2 | 25.0% | +100.0% |
| ALBERS, KEVIN S | 1 | 25.4% | +50.4% |
| QIAN, SHIZHI | 1 | 62.0% | +46.2% |
| SHEN, YANXIN NMN | 1 | 84.6% | +26.4% |
| HOEKSTRA, JEFFREY GERBEN | 1 | 56.1% | +39.8% |
| HASTINGS, ALISON AZAR | 1 | 62.5% | +42.1% |
| WEDDINGTON, KEVIN E | 1 | 75.3% | +9.8% |
| MCDOWELL, BRIAN E | 1 | 74.0% | +31.0% |
| AULAKH, CHARANJIT | 1 | 80.7% | -14.5% |
| HOBSON, STEPHEN | 1 | 65.0% | +20.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18895992 | METHODS OF DECREASING TOTAL ALKALOID CONTENT IN TOBACCO | SHEN, YANXIN NMN | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18249143 | IMPROVED FLOCCULANTS | PERRIN, CLARE M | 4d overdue |
| 17797687 | ELECTROWINNING CELLS FOR THE SEGREGATION OF THE CATHODIC AND ANODIC COMPARTMENTS | MENDEZ, ZULMARIAM | 4d overdue |
| 18498834 | USING siRNAs AGAINST TAU CIRCULAR RNAS AS A RATIONAL THERAPY FOR ALZHEIMER'S DISEASE | TATGE, LEXUS MARC | 13d |
| 17219111 | Compositions and Methods for Inhibiting Growth of Lactic Acid Producing Bacteria | BREEN, KIMBERLY CATHERINE | 26d |
| 17696714 | USE OF ANIMAL BY-PRODUCTS FOR CEMENT PRODUCTION | CHAU, LISA N | 28d |
| 18282788 | MORTAR MIX AND CONCRETE MIX INCORPORATING A STILLAGE LIQUID | LOUGHRAN, RYAN PATRICK | 70d |
| 19060167 | SURGERY PLATFORM WITH A ROTATING SURFACE ON A STATIONARY BASE WITH INTEGRATED GAS LINES, INTEGRATED HEATING ELEMENTS, AND LEG POSITIONING STRAP SYSTEM | ALBERS, KEVIN S | — |
| 18849112 | BONE BIOPSY ASSEMBLY WITH LOST MOTION RECEIVER | HOEKSTRA, JEFFREY GERBEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18498834 | USING siRNAs AGAINST TAU CIRCULAR RNAS AS A RATIONAL THERAPY FOR ALZHEIMER'S DISEASE | TATGE, LEXUS MARC | 13d |
| 19060167 | SURGERY PLATFORM WITH A ROTATING SURFACE ON A STATIONARY BASE WITH INTEGRATED GAS LINES, INTEGRATED HEATING ELEMENTS, AND LEG POSITIONING STRAP SYSTEM | ALBERS, KEVIN S | — |
| 18943349 | CROSS-GAP-NANOPORE HETEROSTRUCTURE DEVICE AND METHOD FOR IDENTIFYING CHEMICAL SUBSTANCE | QIAN, SHIZHI | — |
| 18895992 | METHODS OF DECREASING TOTAL ALKALOID CONTENT IN TOBACCO | SHEN, YANXIN NMN | — |
| 18849112 | BONE BIOPSY ASSEMBLY WITH LOST MOTION RECEIVER | HOEKSTRA, JEFFREY GERBEN | — |
| 18889177 | UNIQUE ANALOGS OF NATURAL LIGNANS USEFUL FOR TREATING TRIPLE NEGATIVE BREAST CANCER | HASTINGS, ALISON AZAR | — |
| 18743737 | Substituted Monohydrazides as Potent Antifungal Agents | MCDOWELL, BRIAN E | — |
| 18665035 | APPARATUS AND METHOD FOR CARBON CAPTURE VIA ELECTROCHEMICAL-MEMBRANE SEPARATION | HOBSON, STEPHEN | — |
| Art Unit | Apps |
|---|---|
| 3791 | 2 |
| 1627 | 2 |
| 1624 | 2 |
| 1637 | 2 |
| 1794 | 2 |
| 3786 | 1 |
| 1795 | 1 |
| 1663 | 1 |
| 1629 | 1 |
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19060167 | SURGERY PLATFORM WITH A ROTATING SURFACE ON A STATIONARY BASE WITH INTEGRATED GAS LINES, INTEGRATED HEATING ELEMENTS, AND LEG POSITIONING STRAP SYSTEM | ALBERS, KEVIN S | 3786 | §103 | Final Rejection | — | Pending | Feb 21, 2025 |
| 18943349 | CROSS-GAP-NANOPORE HETEROSTRUCTURE DEVICE AND METHOD FOR IDENTIFYING CHEMICAL SUBSTANCE | QIAN, SHIZHI | 1795 | §103 | Non-Final OA | — | Pending | Nov 11, 2024 |
| 18895992 | METHODS OF DECREASING TOTAL ALKALOID CONTENT IN TOBACCO | SHEN, YANXIN NMN | 1663 | §103§112DP | Non-Final OA | — | Pending | Sep 25, 2024 |
| 18849112 | BONE BIOPSY ASSEMBLY WITH LOST MOTION RECEIVER | HOEKSTRA, JEFFREY GERBEN | 3791 | §101§102§112 | Non-Final OA | — | Pending | Sep 20, 2024 |
| 18889177 | UNIQUE ANALOGS OF NATURAL LIGNANS USEFUL FOR TREATING TRIPLE NEGATIVE BREAST CANCER | HASTINGS, ALISON AZAR | 1627 | §101§102§103§112 | Non-Final OA | — | Pending | Sep 18, 2024 |
| 18750348 | TRIMERIC COPPER CATALYSTS, INTERMEDIATES FOR MAKING SUCH CATALYSTS AND METHOD FOR PREPARING A CYCLOADDITION COMPOUND | WEDDINGTON, KEVIN E | 1629 | §102 | Non-Final OA | — | Pending | Jun 21, 2024 |
| 18743737 | Substituted Monohydrazides as Potent Antifungal Agents | MCDOWELL, BRIAN E | 1624 | §102§112Other | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18716131 | DIAMINOBUTOXY-SUBSTITUTED ISOFLAVONOIDS AS MITOCHONDRIAL COMPLEX I INHIBITORS FOR CANCER TREATMENT | AULAKH, CHARANJIT | 1621 | §103§112 | Final Rejection | — | Pending | Jun 03, 2024 |
| 18665035 | APPARATUS AND METHOD FOR CARBON CAPTURE VIA ELECTROCHEMICAL-MEMBRANE SEPARATION | HOBSON, STEPHEN | 1776 | §102 | Non-Final OA | — | Pending | May 15, 2024 |
| 18685208 | DOWNREGULATION OF CIRCULATING GHRELIN AND THERAPEUTIC APPLICATIONS THEREOF | IANNUZO, NATALIE NMN | 1653 | §102§103§112 | Non-Final OA | — | Pending | Feb 20, 2024 |
| 18545717 | TARGETING AND TREATMENT OF CANCEROUS CELLS USING RADIOLABELED GRP78-BINDING AGENTS | SCHLIENTZ, LEAH H | 1618 | §102§103 | Non-Final OA | — | Pending | Dec 19, 2023 |
| 18567315 | TREATMENT FOR AORTOPATHY | TATGE, LEXUS MARC | 1637 | §103§112 | Final Rejection | — | Pending | Dec 05, 2023 |
| 18389398 | Carbon Capture System with Temperature Controlled Absorber Bottom | SLAUGOVSKY, RACHEL MARIE | 1736 | §103§112 | Non-Final OA | — | Pending | Nov 14, 2023 |
| 18498834 | USING siRNAs AGAINST TAU CIRCULAR RNAS AS A RATIONAL THERAPY FOR ALZHEIMER'S DISEASE | TATGE, LEXUS MARC | 1637 | §101§102§103Other | Final Rejection | 13d | Pending | Oct 31, 2023 |
| 18557411 | Dual-Color CsPbBr3 Nanocrystals Prepared by Water | GROOMS, NOA WILLIAM FRAN | 1759 | §103§112 | Final Rejection | — | Pending | Oct 26, 2023 |
| 18370558 | TREATMENTS FOR BLOOD-BRAIN BARRIER DYSFUNCTION AND RECURRENT SEIZURES USING NOX/LOX/COX INHIBITORS | PIHONAK, SARAH | 1627 | §103DP | Final Rejection | 6d | Pending | Sep 20, 2023 |
| 18282788 | MORTAR MIX AND CONCRETE MIX INCORPORATING A STILLAGE LIQUID | LOUGHRAN, RYAN PATRICK | 1731 | §103§112 | Final Rejection | 70d | Pending | Sep 19, 2023 |
| 18281743 | APPARATUS FOR PLACING A NEEDLE AT A SPECIFIC LOCATION AND DEPTH USING AN ULTRASOUND PROBE | TON, MARTIN TRUYEN | 3771 | §103 | Non-Final OA | 6d | Pending | Sep 12, 2023 |
| 18277359 | RECOVERY OF VALUABLE MATERIALS AND GRAPHITE FROM END-OF-LIFE LITHIUM-ION BATTERIES | OHARA, BRIAN R | 1724 | §102§103 | Non-Final OA | — | Pending | Aug 15, 2023 |
| 18213054 | METHOD AND SYSTEM FOR RECYCLING LITHIUM ION BATTERIES USING ELECTROCHEMICAL LITHIUM ION PURIFICATION | CONTRERAS, CIEL P | 1794 | §103§112 | Non-Final OA | — | Pending | Jun 22, 2023 |
| 18142427 | HOLLOW FIBER MEMBRANE FOR ENCLOSED SPACE AIR REMEDIATION | ASHIMIU, MAUTIN ISAAC | 3785 | §103 | Non-Final OA | 12d | Pending | May 02, 2023 |
| 18249143 | IMPROVED FLOCCULANTS | PERRIN, CLARE M | 1779 | §103§112 | Final Rejection | 4d overdue | Pending | Apr 14, 2023 |
| 18029057 | MULTI-COORDINATE GOLD-PHOSPHINE COMPOUNDS AND METHOD OF USE | SAMSELL, RILLA MARIE | 1624 | §112DP | Non-Final OA | 31d overdue | Pending | Mar 28, 2023 |
| 17927389 | Identifying Risk of Cerebra Edema | VOLKOV, ALEXANDER ALEXANDROVIC | 1677 | §101§103§112 | Final Rejection | — | Pending | Nov 23, 2022 |
| 17959809 | BIOERODIBLE LIFE SUPPORT HYDROGELS FOR THE DELIVERY OF VIABLE MITOCHONDRIA | TAKENAKA, RISA | 1632 | §103 | Final Rejection | 31d overdue | Pending | Oct 04, 2022 |
| 17908827 | Manipulating Glycogen in Alzheimer's Disease, Epilepsy, Traumatic Brain Injury, and ALS as a Treatment | WANG, CHANG YU | 1675 | §112 | Final Rejection | 15d overdue | Pending | Sep 01, 2022 |
| 17797687 | ELECTROWINNING CELLS FOR THE SEGREGATION OF THE CATHODIC AND ANODIC COMPARTMENTS | MENDEZ, ZULMARIAM | 1794 | §102§103 | Non-Final OA | 4d overdue | Pending | Aug 04, 2022 |
| 17696714 | USE OF ANIMAL BY-PRODUCTS FOR CEMENT PRODUCTION | CHAU, LISA N | 1785 | §103§112 | Final Rejection | 28d | Pending | Mar 16, 2022 |
| 17622408 | BONE BIOPSY SYSTEM AND METHOD | HOFFPAUIR, ANDREW ELI | 3791 | §103 | Final Rejection | 20d | Pending | Dec 23, 2021 |
| 17440544 | A Novel Prostate Apoptosis Response-4 (Par-4) Protein Entity with an Extended Duration of Action for Therapeutic Treatment of Cancer | HOLTZMAN, KATHERINE ANN | 1646 | §102§103 | Non-Final OA | — | Pending | Sep 17, 2021 |
| 17283626 | ENDOGENOUS CYTOPLASMIC ALU COMPLEMENTARY DNA IN AGE-RELATED MACULAR DEGENERATION | MCLEOD, AFRICA MHAIRIE | 1635 | §103 | Final Rejection | — | Pending | Apr 08, 2021 |
| 17219111 | Compositions and Methods for Inhibiting Growth of Lactic Acid Producing Bacteria | BREEN, KIMBERLY CATHERINE | 1657 | §101§102 | Final Rejection | 26d | Pending | Mar 31, 2021 |
| 17014164 | AIR PREHEATER AND METHOD OF DECOMPOSING AND REMOVING AMMONIUM BISULFATE FROM A REGENERATIVE HEATING ELEMENT OF THAT AIR PREHEATER | MEILLER, SEAN V | 3741 | §103 | Final Rejection | 61d | Pending | Sep 08, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Kentucky Research Foundation has 33 pending office actions as of October 2026, spread across 28 art units and 32 examiners.
Lexus Marc Tatge has the most, with 2 of University of Kentucky Research Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
